Listed

Veracyte, Inc.

VCYTNasdaqCIK 1384101HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$150.3mRevenue, Q2 FY2026, three months to 2026-06-30$150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 31, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$150.3mRevenue, Q2 FY2026, three months to 2026-06-30$150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure+15.5% on a year earlier
  • Gross margin72.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $108.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure+3.2 pts on a year earlier
  • Operating margin15.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure+19.3 pts on a year earlier
  • Net margin17.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $25.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure+17.7 pts on a year earlier
  • Diluted EPS$0.31Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figureSign changed from a year earlier
  • Free cash flow$43.0mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $45.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001384101-26-000044. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001384101-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure+32.9% on a year earlier

Last eight quarters

Full statements
Revenue$150.3mGross margin 72.2%
Diluted EPS$0.31, Q2 FY2026
Free cash flow$43.0m, Q2 FY2026
Veracyte, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m116Revenue, Q3 FY2024, three months to 2024-09-30$115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure119Revenue, Q4 FY2024, three months to 2024-12-31$118.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure114Revenue, Q1 FY2025, three months to 2025-03-31$114.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure130Revenue, Q2 FY2025, three months to 2025-06-30$130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure132Revenue, Q3 FY2025, three months to 2025-09-30$131.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure141Revenue, Q4 FY2025, three months to 2025-12-31$140.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure139Revenue, Q1 FY2026, three months to 2026-03-31$139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure150Revenue, Q2 FY2026, three months to 2026-06-30$150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure
Gross margin%68.2%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $79.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Revenue: $115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure66.4%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $78.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $118.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure69.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $79.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Revenue: $114.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure69.0%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $89.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure69.2%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $91.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Revenue: $131.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure72.5%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $102.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $140.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure72.7%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $101.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Revenue: $139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure72.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $108.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure
Operating margin%10.4%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Revenue: $115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure3.5%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $118.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure2.5%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Revenue: $114.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure(4.0%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure17.4%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $22.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Revenue: $131.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure26.4%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $37.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $140.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure16.3%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $22.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Revenue: $139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure15.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure
Net margin%13.1%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Revenue: $115.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure4.3%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $118.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure6.2%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Revenue: $114.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure(0.8%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$980.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure14.5%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $19.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Revenue: $131.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figure29.3%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $41.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $140.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure20.6%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $28.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Revenue: $139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure17.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $25.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Revenue: $150.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure
Diluted EPS$ per share0.19Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figurenot reported (Diluted EPS not reported)0.09Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure(0.01)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure0.24Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001384101-25-000130.Report this figurenot reported (Diluted EPS not reported)0.35Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure0.31Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-31, accession 0001384101-26-000044.Report this figure
Free cash flow$m27.7Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $30.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001384101-25-000130. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001384101-25-000130. Derived: 9-month figure less the 6-month figure.Report this figure20.4Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $24.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure3.5Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure32.3Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $33.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001384101-26-000044. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001384101-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure42.0Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $44.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001384101-25-000130. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001384101-25-000130. Derived: 9-month figure less the 6-month figure.Report this figure48.8Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $52.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001384101-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure32.3Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $35.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Capital expenditure: $3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001384101-26-000031.Report this figure43.0Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $45.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-31, accession 0001384101-26-000044. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-31, accession 0001384101-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$517.1mGross margin 70.1%
Diluted EPS$0.82, FY2025
Free cash flow$126.6m, FY2025
Veracyte, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m220Revenue, FY2021, twelve months to 2021-12-31$219.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001384101-24-000017.Report this figure297Revenue, FY2022, twelve months to 2022-12-31$296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001384101-25-000014.Report this figure361Revenue, FY2023, twelve months to 2023-12-31$361.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure446Revenue, FY2024, twelve months to 2024-12-31$445.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure517Revenue, FY2025, twelve months to 2025-12-31$517.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure
Gross margin%not reported (Gross profit not reported)59.2%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $175.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-28, accession 0001384101-25-000014.Revenue: $296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001384101-25-000014.Report this figure63.6%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $229.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $361.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure66.9%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $298.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $445.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure70.1%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $362.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $517.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure
Operating margin%(37.3%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$81.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-29, accession 0001384101-24-000017.Revenue: $219.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001384101-24-000017.Report this figure(13.9%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$41.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-28, accession 0001384101-25-000014.Revenue: $296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001384101-25-000014.Report this figure(23.8%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$85.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $361.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure3.6%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $445.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure11.2%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $57.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $517.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure
Net margin%(34.4%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$75.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-29, accession 0001384101-24-000017.Revenue: $219.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-29, accession 0001384101-24-000017.Report this figure(12.3%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$36.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-28, accession 0001384101-25-000014.Revenue: $296.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-28, accession 0001384101-25-000014.Report this figure(20.6%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$74.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $361.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure5.4%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $24.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $445.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure12.8%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $66.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001384101-26-000010.Revenue: $517.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure
Diluted EPS$ per share(1.11)Diluted EPS, FY2021, twelve months to 2021-12-31−$1.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-29, accession 0001384101-24-000017.Report this figure(0.51)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-28, accession 0001384101-25-000014.Report this figure(1.02)Diluted EPS, FY2023, twelve months to 2023-12-31−$1.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure0.31Diluted EPS, FY2024, twelve months to 2024-12-31$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure0.82Diluted EPS, FY2025, twelve months to 2025-12-31$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure
Free cash flow$m(37.0)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$31.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-29, accession 0001384101-24-000017.Capital expenditure: $5.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-29, accession 0001384101-24-000017.Report this figure(1.0)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-28, accession 0001384101-25-000014.Capital expenditure: $8.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-28, accession 0001384101-25-000014.Report this figure34.3Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $44.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001384101-26-000010.Capital expenditure: $10.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure63.8Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $75.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001384101-26-000010.Capital expenditure: $11.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure127Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $136.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001384101-26-000010.Capital expenditure: $9.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001384101-26-000010.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

By month, by reported value, last 24 monthsPurchases $0Sales $1.5m
Veracyte, Inc., open-market insider transactions
DateInsiderTransactionSharesReported priceValueFiling
2026-10-27Eastham KarinDirector Sale14,850$50.0049$742.6kForm 4
2026-10-27Holstein JensDirector Sale7,500$50.00$375.0kForm 4
2026-09-24Holstein JensDirector Sale7,500$47.00$352.5kForm 4

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Veracyte, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$792.1m13,486,437Added+313,819
FMR LLC2026-06-30$452.4m7,702,746Reduced−61,103
Artisan Partners Limited Partnership2026-06-30$325.3m5,538,404Added+42,034
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$277.0m4,716,191Added+271,461
STATE STREET CORP2026-06-30$276.0m4,698,128Reduced−345,462
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$211.1m3,593,922Added+61,690
DIMENSIONAL FUND ADVISORS LP2026-06-30$166.0m2,826,524Reduced−54,566
FIRST TRUST ADVISORS LP2026-06-30$147.3m2,507,902Added+390,856
ARK Investment Management LLC2026-06-30$134.8m2,295,951Reduced−757,867
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$133.6m2,274,160Reduced−284,125

Recent filings

All 1,162 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Veracyte, Inc., recent filings
FiledFormWhat it isAccession number
2026-09-1416:07 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001384101-26-000049
2026-07-3116:11 ET10-QQuarterly reportPeriod 2026-06-300001384101-26-000044
2026-07-3016:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-26-000042
2026-06-1116:32 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001384101-26-000038
2026-05-0608:07 ET10-QQuarterly reportPeriod 2026-03-310001384101-26-000031
2026-05-0516:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-26-000029
2026-04-2216:06 ETDEF 14AProxy statementPeriod 2026-06-100001384101-26-000021
2026-03-1616:17 ET8-K5.02 Departure or appointment of officers or directors0001384101-26-000012
2026-02-2616:32 ET10-KAnnual reportPeriod 2025-12-310001384101-26-000010
2026-02-2516:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001384101-26-000008

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 26, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1384101
Tickers
VCYT
Exchange
Nasdaq
SIC code
8071 Services-Medical Laboratories
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
CALDEROME INC (to 2008-02-27)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.